G

Genesis Research Services | Newcastle, Australia

Research site

(Unclaimed)

Location

220 Denison street Broadmeadow 2292, Newcastle, New South Wales, Australia

Site insights

Top conditions

Top treatments

Xanamem®

LY3009104

Baricitinib

Rimegepant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting

Rheumatoid Arthritis

Drug: Baricitinib

Drug: TNF Inhibitor

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy. (ALKIVIA)

This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammator...

Enrolling

Dermatomyositis

Myositis

Biological: EFG PH20 SC

Other: PBO

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate...

Enrolling

Migraine

Drug: Placebo

Drug: Rimegepant

SBD121, a Synbiotic Medical Food for RA Management

The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and...

Enrolling

Rheumatoid Arthritis

Other: Placebo

Other: SBD121